Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial

Launched by CHINA MEDICAL UNIVERSITY HOSPITAL · Mar 1, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the use of acupuncture as a complementary treatment for people with glaucoma, a condition that affects the eyes and can lead to vision loss if not managed properly. The researchers are looking for 50 participants who have been diagnosed with mild to moderate primary open-angle glaucoma at least three months ago and are currently using one or two types of glaucoma medications. Participants must be at least 20 years old and agree to the study's procedures.

If you join the trial, you can expect to receive acupuncture treatments over a period of 12 weeks. The goal is to see if acupuncture can help lower eye pressure, which is important for managing glaucoma. This study is currently recruiting participants, and it aims to provide valuable information that could help shape future treatment guidelines for glaucoma. However, certain conditions may disqualify you from participating, such as recent eye surgery or specific eye diseases.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Primary open angle glaucoma diagnosed at least 3 months ago.
• • 2. Diagnosed with mild or moderate open angel glaucoma.
• • 3. Use 1 or 2 kinds of glaucoma drugs.
• • 4. Age ≥ 20 years old.
• • 5. Participants sign the informed consent and cooperate with the experimental procedures.
• Exclusion Criteria:
• • 1. Accept any ophthalmic laser or surgery within one year.
• • 2. High myopia.
• • 3. Use of any drugs that affect intraocular pressure.
• • 4. Visual acuity with correction lower than 0.2.
• • 5. Previous or existing uveitis or retinopathy.
• • 6. Unable to receive acupuncture treatment continuously or allergic to acupuncture needles.
• • 7. Pregnancy or breastfeeding.
• • 8. Refusal to sign the informed consent form.